Theorem Clinical Research Names Mooney as Senior Vice President of Global Clinical Development

Theorem Clinical Research Names Mooney as Senior Vice President of Global Clinical Development

KING OF PRUSSIA, Pa., Apr 17, 2012 (BUSINESS WIRE) -- Theorem Clinical Research, a full-service contract research organization (CRO) that provides core clinical research and development services, has named Brian Mooney senior vice president of global clinical development.

Mooney, a graduate of Trenton State College in Ewing, N.J., with a degree in biology, has more than 25 years of experience within the CRO industry. Previously, he worked for Pharmaceutical Research Associates (PRA) International and held the position as senior vice president of project services. Over the course of his tenure, Mooney was responsible for a variety of operational disciplines including global project management, operations in the southern hemisphere and Europe, global study start-up, business solutions and central document management. He earned the company's President's Award in 2001 and 2003.

Prior to PRA International, Mooney was the project manager/program director for Corning Besselaar where he was responsible for the delivery of operational and financial performance. In 1995, he was inducted into the Corning Life Sciences Inc. President's Circle.

"As we move our company forward, we need an experienced leader," stated Theorem Clinical Research Chief Executive Officer John Potthoff. "Brian's expertise and leadership experience within the industry is extensive and provides an excellent foundation for our goals."

About Theorem Clinical Research Theorem Clinical Research is one of the industry's leading full-service, contract research organizations (CRO). Before launching in 2011, Theorem Clinical Research operated for nearly two decades as Omnicare Clinical Research under the Omnicare Inc. parent company. A global organization with 1,000+ employees located throughout 32 countries, Theorem Clinical Research provides core CRO services for Phases I-IV, but with niche business units in the areas of technical services, medical devices and pharmaceutics with speed, flexibility and attention to detail to drive a high-quality performance. For more information, visit .

SOURCE: Theorem Clinical Research

Theorem Clinical Research
Shawn Clary, 484-679-2400
[email protected]

Suggested Articles

The coronavirus is now putting a strain on CROs and researchers in affected areas.

Synteract has boosted its reach into the Asia-Pacific region and South Africa after snapping up a specialty biometrics CRO.

It’s a tale as old as time: Drug development can be a slow, expensive and laborious task and, more often than not, yields failure.